Mass cytometry (cytometry by time-of-flight detection
[CyTOF])
is a bioanalytical technique that enables the identification and quantification
of diverse features of cellular systems with single-cell resolution.
In suspension mass cytometry, cells are stained with stable heavy-atom
isotope-tagged reagents, and then the cells are nebulized into an
inductively coupled plasma time-of-flight mass spectrometry (ICP-TOF-MS)
instrument. In imaging mass cytometry, a pulsed laser is used to ablate
ca. 1 μm2 spots of a tissue section. The plume is
then transferred to the CyTOF, generating an image of biomarker expression.
Similar measurements are possible with multiplexed ion bean imaging
(MIBI). The unit mass resolution of the ICP-TOF-MS detector allows
for multiparametric analysis of (in principle) up to 130 different
parameters. Currently available reagents, however, allow simultaneous
measurement of up to 50 biomarkers. As new reagents are developed,
the scope of information that can be obtained by mass cytometry continues
to increase, particularly due to the development of new small molecule
reagents which enable monitoring of active biochemistry at the cellular
level. This review summarizes the history and current state of mass
cytometry reagent development and elaborates on areas where there
is a need for new reagents. Additionally, this review provides guidelines
on how new reagents should be tested and how the data should be presented
to make them most meaningful to the mass cytometry user community.